US Stock MarketDetailed Quotes
NRBO NeuroBo Pharmaceuticals
- 2.5300
- -0.1400-5.24%
Close Nov 4 16:00 ET
- 2.6200
- +0.0900+3.56%
Post 16:54 ET
21.47MMarket Cap-507P/E (TTM)
2.8350High2.4100Low55.10KVolume2.5000Open2.6700Pre Close139.95KTurnover2.66%Turnover RatioLossP/E (Static)8.49MShares6.749952wk High1.13P/B5.24MFloat Cap2.080052wk Low--Dividend TTM2.07MShs Float129539.9482Historical High--Div YieldTTM15.92%Amplitude2.0800Historical Low2.5390Avg Price1Lot Size
NeuroBo Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -254.57%-7.25M | -152.93%-6.44M | 7.80%-10.8M | -87.77%-3.39M | -19.29%-2.81M | 24.73%-2.05M | 47.26%-2.55M | 22.61%-11.71M | 37.67%-1.81M | 5.90%-2.36M |
| Net income from continuing operations | -1,269.62%-10.05M | -157.83%-6.71M | 10.72%-12.47M | -13.64%-5.31M | -22.65%-3.82M | 77.78%-734K | 9.43%-2.6M | 8.62%-13.97M | -2.14%-4.68M | 10.05%-3.11M |
| Operating gains losses | 104.33%133K | -16.67%70K | 47.87%-2.96M | 99.06%-54K | --87K | ---3.07M | --84K | ---5.67M | ---5.74M | --0 |
| Depreciation and amortization | --6K | 300.00%4K | -70.00%6K | 300.00%4K | -50.00%1K | --0 | -91.67%1K | -58.33%20K | -91.67%1K | -83.33%2K |
| Other non cash items | --0 | --1K | -99.99%1K | -100.05%-4K | ---- | ---- | ---- | 34,141.67%8.22M | 136,733.33%8.21M | --0 |
| Change In working capital | 45.60%2.53M | 100.00%92K | 476.46%4.4M | 919.02%1.88M | 38.39%739K | 492.83%1.74M | 102.11%46K | -100.00%-1.17M | -87.51%184K | -35.59%534K |
| -Change in prepaid assets | 4.35%192K | -39.24%-699K | 9.38%70K | -66.57%231K | -57.57%157K | -64.13%184K | 66.75%-502K | -83.84%64K | 12.36%691K | 160.56%370K |
| -Change in payables and accrued expense | 50.48%2.34M | 44.34%791K | 451.22%4.33M | 424.26%1.64M | 254.88%582K | 805.91%1.55M | 181.91%548K | -25.71%-1.23M | -159.09%-507K | -76.13%164K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -254.57%-7.25M | -152.93%-6.44M | 7.80%-10.8M | -87.77%-3.39M | -19.29%-2.81M | 24.73%-2.05M | 47.26%-2.55M | 22.61%-11.71M | 37.67%-1.81M | 5.90%-2.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3K | -25.00%-5K | -725.00%-50K | -9K | -37K | 0 | -4K | 101.37%8K | 0 | 0 |
| Net PPE purchase and sale | ---3K | -25.00%-5K | -725.00%-50K | ---9K | ---37K | --0 | ---4K | 366.67%8K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---3K | -25.00%-5K | -725.00%-50K | ---9K | ---37K | --0 | ---4K | 101.37%8K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.28%-80K | 0 | 0 | 30.21%28.68M | 123.61%28.82M | -458.33%-134K | ||||
| Net preferred stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --32.25M | ---- | ---- |
| Net other financing activities | ---- | ---- | 97.76%-80K | --0 | --0 | ---- | ---- | -70.85%-3.57M | -196.89%-3.44M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 24,100.00%19.2M | --0 | -100.28%-80K | --0 | --0 | ---80K | --0 | 30.21%28.68M | 123.61%28.82M | -458.33%-134K |
| Net cash flow | ||||||||||
| Beginning cash position | -48.11%15.99M | -32.76%22.44M | 103.60%33.36M | 306.50%25.84M | 224.19%28.69M | 166.62%30.81M | 103.60%33.36M | 62.42%16.39M | -8.99%6.36M | -6.98%8.85M |
| Current changes in cash | 662.16%11.95M | -152.72%-6.45M | -164.38%-10.93M | -112.60%-3.4M | -14.36%-2.85M | 21.56%-2.13M | 47.17%-2.55M | 169.22%16.98M | 187.20%27.01M | 1.50%-2.49M |
| End cash Position | -2.63%27.93M | -48.11%15.99M | -32.76%22.44M | -32.76%22.44M | 306.50%25.84M | 224.19%28.69M | 166.62%30.81M | 103.60%33.36M | 103.60%33.36M | -8.99%6.36M |
| Free cash flow | -254.72%-7.25M | -152.72%-6.45M | 7.37%-10.85M | -88.27%-3.4M | -20.86%-2.85M | 24.73%-2.05M | 47.17%-2.55M | 22.63%-11.71M | 37.67%-1.81M | 5.90%-2.36M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data